Cerity Partners LLC Grows Stock Position in Danaher Corporation $DHR

Cerity Partners LLC increased its holdings in Danaher Corporation (NYSE:DHRFree Report) by 8.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 361,550 shares of the conglomerate’s stock after buying an additional 29,134 shares during the period. Cerity Partners LLC’s holdings in Danaher were worth $82,766,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in DHR. LPL Financial LLC raised its stake in Danaher by 11.3% in the 4th quarter. LPL Financial LLC now owns 507,746 shares of the conglomerate’s stock valued at $116,233,000 after purchasing an additional 51,672 shares during the last quarter. Franklin Resources Inc. raised its stake in Danaher by 14.9% in the 4th quarter. Franklin Resources Inc. now owns 4,931,303 shares of the conglomerate’s stock valued at $1,128,874,000 after purchasing an additional 637,666 shares during the last quarter. Erste Asset Management GmbH raised its stake in Danaher by 251.0% in the 4th quarter. Erste Asset Management GmbH now owns 59,369 shares of the conglomerate’s stock valued at $13,702,000 after purchasing an additional 42,456 shares during the last quarter. O Shaughnessy Asset Management LLC raised its stake in Danaher by 38.3% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 110,725 shares of the conglomerate’s stock valued at $25,347,000 after purchasing an additional 30,692 shares during the last quarter. Finally, Manchester Capital Management LLC raised its stake in Danaher by 2.0% in the 4th quarter. Manchester Capital Management LLC now owns 3,319 shares of the conglomerate’s stock valued at $760,000 after purchasing an additional 64 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Up 2.6%

Shares of NYSE:DHR opened at $188.38 on Wednesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market capitalization of $133.33 billion, a P/E ratio of 36.44, a PEG ratio of 2.45 and a beta of 0.81. The stock has a 50-day simple moving average of $181.33 and a 200-day simple moving average of $205.56.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the business earned $1.88 EPS. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. Equities analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s payout ratio is presently 30.95%.

Analyst Ratings Changes

Several brokerages recently weighed in on DHR. Barclays cut their target price on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Robert W. Baird cut their target price on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Argus dropped their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Finally, Morgan Stanley dropped their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $235.14.

Read Our Latest Stock Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.